PatientsVille.com Logo

PatientsVille

Coraspin Side Effects

Common Coraspin Side Effects


The most commonly reported Coraspin side effects (click to view or check a box to report):

Cardiac Pacemaker Insertion (3)
Death (2)
Cardiac Disorder (2)
Coronary Artery Occlusion (2)
Bronchitis (2)
Arrhythmia (2)
Tension (1)
Rib Fracture (1)
Small Intestinal Haemorrhage (1)
Gingival Bleeding (1)
Respiratory Arrest (1)
Haemoptysis (1)
Unevaluable Event (1)
Hypersensitivity (1)
Nephropathy (1)
Overdose (1)
Intestinal Haemorrhage (1)
Headache (1)
Palpitations (1)
Paraplegia (1)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Coraspin Side Effects Reported to FDA

The following Coraspin reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Coraspin on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Arrhythmia
This is a report of a male patient (weight: NA) from TR, suffering from the following symptoms/conditions: NA, who was treated with Coraspin (dosage: 100 Mg, Qd, start time: NS), combined with:
  • Plavix (75 Mg, Qd)
  • Coumadin
  • Delix (5 Mg, Qd)
  • Avastin (20 Mg, Qd)
  • Nebivolol Hydrochloride
  • Digoxin
and developed a serious reaction and side effect(s). The consumer presented with:
  • Arrhythmia
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Coraspin treatment in male patients, resulting in arrhythmia side effect. The patient was hospitalized.

Haemoptysis, Blister, Dyspnoea
This report suggests a potential Coraspin Haemoptysis, Blister, Dyspnoea side effect(s) that can have serious consequences. A female patient (weight: NA) from TR was diagnosed with the following symptoms/conditions: NA and used Coraspin (dosage: 100 Mg, Qd) starting NS. Soon after starting Coraspin the patient began experiencing various side effects, including:
  • Haemoptysis
  • Blister
  • Dyspnoea
Drugs used concurrently: NA.The patient was hospitalized. Although Coraspin demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as haemoptysis, may still occur.

Epistaxis, Gingival Bleeding, Unevaluable Event, Rib Fracture
This Epistaxis, Gingival Bleeding, Unevaluable Event, Rib Fracture problem was reported by a consumer or non-health professional from TR. A female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On NS this consumer started treatment with Coraspin (dosage: 100 Mg, Qd). The following drugs were being taken at the same time:
  • Rytmonorm (150 Mg, Bid)
  • Coumadin (Unk)
When commencing Coraspin, the patient experienced the following unwanted symptoms/side effects:
  • Epistaxis
  • Gingival Bleeding
  • Unevaluable Event
  • Rib Fracture
The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as epistaxis, may become evident only after a product is in use by the general population.

Gastric Haemorrhage, Facial Bones Fracture, Hypersensitivity
This is a report of a male patient (weight: NA) from TR. The patient developed the following symptoms/conditions: NA and was treated with Coraspin (dosage: 100 Mg, Unk) starting Jan 01, 2012. Concurrently used drugs:
  • Beloc (50 Mg, Unk)
  • Statin
  • Ecopirin (100 Mg, Qd)
Soon after that, the consumer experienced the following side effects:
  • Gastric Haemorrhage
  • Facial Bones Fracture
  • Hypersensitivity
This opens a possibility that Coraspin treatment could cause the above reactions, including gastric haemorrhage, and some male subjects may be more susceptible.


Palpitations, Headache
A male patient (weight: NA) from TR with the following symptoms/conditions: atrial fibrillation started Coraspin treatment (dosage: 300 Mg, Qd) on NS. Soon after starting Coraspin treatment, the subject experienced various side effects, including:
  • Palpitations
  • Headache
Concurrently used drugs:
  • Coumadin (100 Mg, Bid)
  • Beloc
The patient was hospitalized. This finding indicates that some male patients could be more vulnerable to Coraspin.

Cardiac Pacemaker Insertion
A male patient from TR (weight: NA) experienced symptoms, such as: coronary artery disease and was treated with Coraspin(dosage: 100 Mg, Qd). The treatment was initiated on NS. After that a consumer reported the following side effect(s):
  • Cardiac Pacemaker Insertion
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Coraspin efficacy:
  • Plavix (12.5 Mg, Qd)
The patient was hospitalized.

Cardiac Pacemaker Insertion, Dyspnoea Exertional
In this report, Coraspin was administered for the following condition: coronary artery disease.A 59-year-old male consumer from TR (weight: NA) started Coraspin treatment (dosage: 100 Mg, Qd) on NS.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Cardiac Pacemaker Insertion
  • Dyspnoea Exertional
A possible interaction with other drugs could have contributed to this reaction:
  • Coumadin (5 Mg, Unk)
  • Dilatrend (25 Mg, Bid)
  • Spironolactone
The patient was hospitalized.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Coraspin treatment could be related to the listed above side effect(s).

Cardiac Pacemaker Insertion, Intestinal Haemorrhage, Arrhythmia, Cardiac Failure, Small Intestinal Haemorrhage, Convulsion, Paraplegia
This is a report of the following Coraspin side effect(s):
  • Cardiac Pacemaker Insertion
  • Intestinal Haemorrhage
  • Arrhythmia
  • Cardiac Failure
  • Small Intestinal Haemorrhage
  • Convulsion
  • Paraplegia
A 49-year-old male patient from TR (weight: NA) presented with the following condition: NA and received a treatment with Coraspin (dosage: 100 Mg, Unk) starting: NS.The following concurrently used drugs could have generated interactions:
  • Digoxin (200 Mg, Unk)
  • Ecopirin
  • Cordarone
  • Beloc (50 Mg, Unk)
  • Insulin
  • Monodur
The patient was hospitalized.This report suggests that a Coraspin treatment could be associated with the listed above side effect(s).

Cardiac Disorder, Diabetes Mellitus, Tension, Nephropathy
This Coraspin report was submitted by a 57-year-old male consumer from TR (weight: NA). The patient was diagnosed with: NA and Coraspin was administered (dosage: 100 Mg, Qd) starting: NS. The consumer developed a set of symptoms:
  • Cardiac Disorder
  • Diabetes Mellitus
  • Tension
  • Nephropathy
Other drugs used simultaneously:
  • Clopidogrel
  • Aspirin
  • Ecopirin
The patient was hospitalized.Those unexpected symptoms could be linked to a Coraspin treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.


This is a report of a possible correlation between Coraspin use and the following symptoms/side effect(s):
    which could contribute to an assessment of Coraspin risk profile.A 48-year-old female consumer from TR (weight: NA) was suffering from NA and was treated with Coraspin (dosage: 100 Mg, Unk) starting NS.Other concurrent medications:
    • Bisoprolol (5 Mg, Unk)



    A 88-year-old male patient from TR (weight: NA) presented with the following symptoms: NA and after a treatment with Coraspin (dosage: 100 Mg, Qd) experienced the following side effect(s):
      The treatment was started on NS. Coraspin was used in combination with the following drugs:
      • Beloc (50 Mg, Unk)
      This report could alert potential Coraspin consumers.

      Gastroduodenal Ulcer, Overdose, Respiratory Arrest, Cerebrovascular Accident
      In this report, a 81-year-old male patient from VENEZUELA (weight: NA) was affected by a possible Coraspin side effect.The patient was diagnosed with NA. After a treatment with Coraspin (dosage: 81 Mg, 1x/day, start date: Jan 01, 2007), the patient experienced the following side effect(s):
      • Gastroduodenal Ulcer
      • Overdose
      • Respiratory Arrest
      • Cerebrovascular Accident
      The following simultaneously used drugs could have led to this reaction:
      • Zoloft (Unk, 1x/day)
      The findings here stress that side effects should be taken into consideration when evaluating a Coraspin treatment.

      Cardiac Disorder, Vomiting
      This is a report of a 73-year-old female patient from VENEZUELA (weight: NA), who used Coraspin (dosage: 81 Mg, 1x/day) for a treatment of NA. After starting a treatment on Jan 01, 2009, the patient experienced the following side effect(s):
      • Cardiac Disorder
      • Vomiting
      The following drugs could possibly have interacted with the Coraspin treatment
      • Enalapril (10 Mg, 1x/day)
      • Lipitor (40 Mg, 1x/day)
      The patient was hospitalized.Taken together, these observations suggest that a Coraspin treatment could be related to side effect(s), such as Cardiac Disorder, Vomiting.

      Bronchitis, Coronary Artery Occlusion
      This bronchitis side effect was reported by a consumer or non-health professional from TURKEY. A male patient (weight:NA) experienced the following symptoms/conditions: NA. The patient was prescribed Coraspin (dosage: 100mg Daily ; 1x1), which was started on Apr 20, 2011. Concurrently used drugs:
      • Lipitor (1x1)
      • Emthexate (2.5 Mg Daily)
      • Spiriva (2x1)
      • Combivent (2x1)
      • Humira
      When starting to take Coraspin the consumer reported the following symptoms:
      • Bronchitis
      • Coronary Artery Occlusion
      The patient was hospitalized. These side effects may potentially be related to Coraspin.

      Bronchitis, Coronary Artery Occlusion
      This is a Coraspin side effect report of a male patient (weight:NA) from TURKEY, suffering from the following symptoms/conditions: NA, who was treated with Coraspin (dosage:100mg Daily ; 1x1, start time: Apr 20, 2011), combined with:
      • Lipitor (1x1)
      • Combivent (2x1)
      • Humira
      • Spiriva (2x1)
      • Emthexate (2.5 Mg Daily)
      , and developed a serious reaction and a bronchitis side effect. The patient presented with:
      • Bronchitis
      • Coronary Artery Occlusion
      which developed after the beginning of treatment. The patient was hospitalized. This side effect report can indicate a possible existence of increased vulnerability to Coraspin treatment in male patients suffering from NA, resulting in bronchitis.



      Keep Track of Side Effects

      Note Your Observations

      It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

      Why Your Notes are Important

      Your notes could be helpful in several ways:

    • You can use them to remind you of details that may alert your health care professional(s) to a problem
    • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

    • Log Form

      You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

      Medicine Name and Dosage:
      Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
      Scale: 1 = very mild to 10 = very bad

      You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


      Discuss Coraspin Side Effects

      Did You Have a Coraspin Side Effect?

      Yes, Severe
      Yes, Moderate
      Yes, Minor
      No

      How Effective is Coraspin for You?

      Exceeded Expectations
      Effective
      Somewhat Effective
      Not Effective

      Coraspin Safety Alerts, Active Ingredients, Usage Information

      More About Coraspin

      Side Effects reported to FDA: 15

      Coraspin safety alerts: No

      Reported deaths: 3

      Reported hospitalizations: 11

      Latest Coraspin clinical trials

      Coraspin Reviews

      No reviews, be a first to report a side effect via side effect reporting form